Vault-13

Integral Health Asset Management, LLC

New York, NY · CIK 1773206 · 13F filing filed 2024-08-14

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$1.0bn reported value -1.4% vs Q1 2024
69positions
47.1%in top 10
22 new 29 added 11 reduced 29 sold out vs Q1 2024

Options: 2 call positions ($37.1m notional), 1 put positions ($10.9m notional) – listed below, not included above.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSMED INC COM PAR $.01 INSM INSM 1,550,000 $103.8m10.34% 10.34% AddedShares held: Q3 2023 0, Q4 2023 350.0k, Q1 2024 1.3m, Q2 2024 1.6m +250.0k +250,000 19.2%
2 TENET HEALTHCARE CORP COM NEW THC THC 500,000 $66.5m6.62% 6.62% AddedShares held: Q3 2023 540.0k, Q4 2023 350.0k, Q1 2024 425.0k, Q2 2024 500.0k +75.0k +75,000 17.6%
3 CYTOKINETICS INC COM NEW CYTK CYTK 1,000,000 $54.2m5.39% 5.39% AddedShares held: Q3 2023 800.0k, Q4 2023 200.0k, Q1 2024 450.0k, Q2 2024 1.0m +550.0k +550,000 122.2%
4 BOSTON SCIENTIFIC CORP COM BSX BSX 650,000 $50.1m4.98% 4.98% AddedShares held: Q3 2023 550.0k, Q4 2023 375.0k, Q1 2024 600.0k, Q2 2024 650.0k +50.0k +50,000 8.3%
5 ELEVANCE HEALTH INC COM ELV ELV 80,000 $43.3m4.31% 4.31% AddedShares held: Q3 2023 25.0k, Q4 2023 20.0k, Q1 2024 50.0k, Q2 2024 80.0k +30.0k +30,000 60.0%
6 BLUEPRINT MEDICINES CORP COM BPMC BPMC 340,000 $36.6m3.65% 3.65% AddedShares held: Q3 2023 50.0k, Q4 2023 140.0k, Q1 2024 210.0k, Q2 2024 340.0k +130.0k +130,000 61.9%
7 NOVARTIS AG SPONSORED ADR NVS NVS 300,000 $31.9m3.18% 3.18% AddedShares held: Q3 2023 200.0k, Q4 2023 225.0k, Q1 2024 225.0k, Q2 2024 300.0k +75.0k +75,000 33.3%
8 LONGBOARD PHARMACEUTICALS IN COM COM 1,100,000 $29.7m2.96% 2.96% AddedShares held: Q3 2023 760.0k, Q4 2023 900.0k, Q1 2024 975.0k, Q2 2024 1.1m +125.0k +125,000 12.8%
9 MERCK & CO INC COM MRK MRK 235,000 $29.1m2.90% 2.90% UnchangedShares held: Q3 2023 50.0k, Q4 2023 0, Q1 2024 235.0k, Q2 2024 235.0k
10 HUMANA INC COM HUM HUM 75,000 $28.0m2.79% 2.79% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 60.0k, Q2 2024 75.0k +15.0k +15,000 25.0%
11 ENCOMPASS HEALTH CORP COM EHC EHC 300,000 $25.7m2.56% 2.56% ReducedShares held: Q3 2023 250.0k, Q4 2023 250.0k, Q1 2024 350.0k, Q2 2024 300.0k -50.0k -50,000 -14.3%
12 UNIVERSAL HLTH SVCS INC CL B UHS UHS 130,000 $24.0m2.39% 2.39% AddedShares held: Q3 2023 0, Q4 2023 70.0k, Q1 2024 125.0k, Q2 2024 130.0k +5.0k +5,000 4.0%
13 INARI MED INC COM NARI NARI 400,000 $19.3m1.92% 1.92% AddedShares held: Q3 2023 350.0k, Q4 2023 100.0k, Q1 2024 200.0k, Q2 2024 400.0k +200.0k +200,000 100.0%
14 VERA THERAPEUTICS INC CL A VERA VERA 500,000 $18.1m1.80% 1.80% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 360.0k, Q2 2024 500.0k +140.0k +140,000 38.9%
15 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 400,000 $17.9m1.78% 1.78% AddedShares held: Q3 2023 200.0k, Q4 2023 200.0k, Q1 2024 325.0k, Q2 2024 400.0k +75.0k +75,000 23.1%
16 BECTON DICKINSON & CO COM BDX BDX 75,000 $17.5m1.74% 1.74% NewShares held: Q3 2023 65.0k, Q4 2023 0, Q1 2024 0, Q2 2024 75.0k
17 THE CIGNA GROUP COM CI CI 50,000 $16.5m1.65% 1.65% AddedShares held: Q3 2023 60.0k, Q4 2023 0, Q1 2024 40.0k, Q2 2024 50.0k +10.0k +10,000 25.0%
18 TARSUS PHARMACEUTICALS INC COM TARS TARS 590,000 $16.0m1.60% 1.60% UnchangedShares held: Q3 2023 0, Q4 2023 100.0k, Q1 2024 590.0k, Q2 2024 590.0k
19 KRYSTAL BIOTECH INC COM KRYS KRYS 85,000 $15.6m1.55% 1.55% AddedShares held: Q3 2023 70.0k, Q4 2023 85.0k, Q1 2024 80.0k, Q2 2024 85.0k +5.0k +5,000 6.2%
20 ARCELLX INC COMMON STOCK ACLX ACLX 275,000 $15.2m1.51% 1.51% AddedShares held: Q3 2023 0, Q4 2023 160.0k, Q1 2024 255.0k, Q2 2024 275.0k +20.0k +20,000 7.8%
21 ICON PLC SHS ICLR ICLR 45,000 $14.1m1.40% 1.40% UnchangedShares held: Q3 2023 0, Q4 2023 35.0k, Q1 2024 45.0k, Q2 2024 45.0k
22 EDWARDS LIFESCIENCES CORP COM EW EW 150,000 $13.9m1.38% 1.38% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 150.0k
23 THERMO FISHER SCIENTIFIC INC COM TMO TMO 25,000 $13.8m1.38% 1.38% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 25.0k
24 QUEST DIAGNOSTICS INC COM DGX DGX 100,000 $13.7m1.36% 1.36% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
25 VIKING THERAPEUTICS INC COM VKTX VKTX 250,000 $13.3m1.32% 1.32% ReducedShares held: Q3 2023 800.0k, Q4 2023 500.0k, Q1 2024 450.0k, Q2 2024 250.0k -200.0k -200,000 -44.4%
26 REVOLUTION MEDICINES INC COM RVMD RVMD 325,000 $12.6m1.26% 1.26% ReducedShares held: Q3 2023 525.0k, Q4 2023 200.0k, Q1 2024 420.0k, Q2 2024 325.0k -95.0k -95,000 -22.6%
27 AMGEN INC COM AMGN AMGN 40,000 $12.5m1.24% 1.24% NewShares held: Q3 2023 65.0k, Q4 2023 0, Q1 2024 0, Q2 2024 40.0k
28 IONIS PHARMACEUTICALS INC COM IONS IONS 250,000 $11.9m1.19% 1.19% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 250.0k
29 MCKESSON CORP COM MCK MCK 20,000 $11.7m1.16% 1.16% NewShares held: Q3 2023 50.0k, Q4 2023 0, Q1 2024 0, Q2 2024 20.0k
30 REGENXBIO INC COM RGNX RGNX 950,000 $11.1m1.11% 1.11% AddedShares held: Q3 2023 0, Q4 2023 325.0k, Q1 2024 760.0k, Q2 2024 950.0k +190.0k +190,000 25.0%
31 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 145,000 $9.9m0.99% 0.99% AddedShares held: Q3 2023 133.0k, Q4 2023 175.0k, Q1 2024 125.0k, Q2 2024 145.0k +20.0k +20,000 16.0%
32 SANOFI SPONSORED ADR SNY SNY 200,000 $9.7m0.97% 0.97% NewShares held: Q3 2023 0, Q4 2023 400.0k, Q1 2024 0, Q2 2024 200.0k
33 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 220,000 $9.7m0.96% 0.96% UnchangedShares held: Q3 2023 500.0k, Q4 2023 220.0k, Q1 2024 220.0k, Q2 2024 220.0k
34 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 70,000 $9.6m0.96% 0.96% ReducedShares held: Q3 2023 85.0k, Q4 2023 90.0k, Q1 2024 150.0k, Q2 2024 70.0k -80.0k -80,000 -53.3%
35 TELEFLEX INCORPORATED COM TFX TFX 45,000 $9.5m0.94% 0.94% NewShares held: Q3 2023 0, Q4 2023 70.0k, Q1 2024 0, Q2 2024 45.0k
36 ELI LILLY & CO COM LLY LLY 10,000 $9.1m0.90% 0.90% ReducedShares held: Q3 2023 25.0k, Q4 2023 28.0k, Q1 2024 12.0k, Q2 2024 10.0k -2.0k -2,000 -16.7%
37 GLOBUS MED INC CL A GMED GMED 125,000 $8.6m0.85% 0.85% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 125.0k
38 BRUKER CORP COM BRKR BRKR 130,000 $8.3m0.83% 0.83% ReducedShares held: Q3 2023 0, Q4 2023 100.0k, Q1 2024 220.0k, Q2 2024 130.0k -90.0k -90,000 -40.9%
39 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 150,000 $8.1m0.81% 0.81% ReducedShares held: Q3 2023 275.0k, Q4 2023 0, Q1 2024 220.0k, Q2 2024 150.0k -70.0k -70,000 -31.8%
40 OSCAR HEALTH INC CL A OSCR OSCR 500,000 $7.9m0.79% 0.79% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 500.0k, Q2 2024 500.0k
41 REPLIGEN CORP COM RGEN RGEN 60,000 $7.6m0.75% 0.75% AddedShares held: Q3 2023 0, Q4 2023 55.0k, Q1 2024 50.0k, Q2 2024 60.0k +10.0k +10,000 20.0%
42 DENALI THERAPEUTICS INC COM DNLI DNLI 325,000 $7.5m0.75% 0.75% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 325.0k
43 TENAYA THERAPEUTICS INC COM TNYA TNYA 2,325,000 $7.2m0.72% 0.72% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.2m, Q2 2024 2.3m +75.0k +75,000 3.3%
44 SANA BIOTECHNOLOGY INC COM SANA SANA 1,200,000 $6.6m0.65% 0.65% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 980.0k, Q2 2024 1.2m +220.0k +220,000 22.4%
45 ELANCO ANIMAL HEALTH INC COM ELAN ELAN 450,000 $6.5m0.65% 0.65% ReducedShares held: Q3 2023 748.0k, Q4 2023 500.0k, Q1 2024 550.0k, Q2 2024 450.0k -100.0k -100,000 -18.2%
46 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 1,775,000 $6.4m0.64% 0.64% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 950.0k, Q2 2024 1.8m +825.0k +825,000 86.8%
47 MERUS N V COM MRUS MRUS 100,000 $5.9m0.59% 0.59% ReducedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 165.0k, Q2 2024 100.0k -65.0k -65,000 -39.4%
48 INSULET CORP COM PODD PODD 25,000 $5.0m0.50% 0.50% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 25.0k
49 QUIDELORTHO CORP COM QDEL QDEL 150,000 $5.0m0.50% 0.50% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 150.0k
50 RELAY THERAPEUTICS INC COM RLAY RLAY 750,000 $4.9m0.49% 0.49% AddedShares held: Q3 2023 800.0k, Q4 2023 600.0k, Q1 2024 725.0k, Q2 2024 750.0k +25.0k +25,000 3.5%
51 SURGERY PARTNERS INC COM SGRY SGRY 200,000 $4.8m0.47% 0.47% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 200.0k
52 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 100,000 $4.5m0.45% 0.45% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
53 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 10,000 $4.4m0.44% 0.44% ReducedShares held: Q3 2023 0, Q4 2023 40.0k, Q1 2024 50.0k, Q2 2024 10.0k -40.0k -40,000 -80.0%
54 CATALYST PHARMACEUTICALS INC COM CPRX CPRX 275,000 $4.3m0.42% 0.42% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 275.0k
55 ROIVANT SCIENCES LTD SHS ROIV ROIV 400,000 $4.2m0.42% 0.42% ReducedShares held: Q3 2023 450.0k, Q4 2023 0, Q1 2024 600.0k, Q2 2024 400.0k -200.0k -200,000 -33.3%
56 KEROS THERAPEUTICS INC COM KROS KROS 85,000 $3.9m0.39% 0.39% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 40.0k, Q2 2024 85.0k +45.0k +45,000 112.5%
57 HOLOGIC INC COM HOLX HOLX 50,000 $3.7m0.37% 0.37% NewShares held: Q3 2023 125.0k, Q4 2023 100.0k, Q1 2024 0, Q2 2024 50.0k
58 89BIO INC COM ETNB ETNB 450,000 $3.6m0.36% 0.36% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 300.0k, Q2 2024 450.0k +150.0k +150,000 50.0%
59 DYNE THERAPEUTICS INC COM DYN DYN 100,000 $3.5m0.35% 0.35% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
60 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 400,000 $3.3m0.33% 0.33% AddedShares held: Q3 2023 0, Q4 2023 100.0k, Q1 2024 325.0k, Q2 2024 400.0k +75.0k +75,000 23.1%
61 CABALETTA BIO INC COM CABA CABA 425,000 $3.2m0.32% 0.32% UnchangedShares held: Q3 2023 330.0k, Q4 2023 520.0k, Q1 2024 425.0k, Q2 2024 425.0k
62 EDITAS MEDICINE INC COM EDIT EDIT 675,000 $3.2m0.31% 0.31% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 450.0k, Q2 2024 675.0k +225.0k +225,000 50.0%
63 APOGEE THERAPEUTICS INC COM COM 80,000 $3.1m0.31% 0.31% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 40.0k, Q2 2024 80.0k +40.0k +40,000 100.0%
64 NURIX THERAPEUTICS INC COM NRIX NRIX 150,000 $3.1m0.31% 0.31% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 150.0k
65 FATE THERAPEUTICS INC COM FATE FATE 850,000 $2.8m0.28% 0.28% AddedShares held: Q3 2023 0, Q4 2023 900.0k, Q1 2024 200.0k, Q2 2024 850.0k +650.0k +650,000 325.0%
66 NEUROGENE INC COM NGNE NGNE 70,000 $2.5m0.25% 0.25% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 70.0k
67 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 100,000 $2.4m0.23% 0.23% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 100.0k, Q2 2024 100.0k
68 KURA ONCOLOGY INC COM KURA KURA 100,000 $2.1m0.20% 0.20% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
69 REVANCE THERAPEUTICS INC COM RVNC RVNC 500,000 $1.3m0.13% 0.13% NewShares held: Q3 2023 100.0k, Q4 2023 450.0k, Q1 2024 0, Q2 2024 500.0k

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
WALGREENS BOOTS ALLIANCE INC WBA WBA 1,300,000 $28.2m1.3m shares
ABBVIE INC ABBV ABBV 135,000 $24.6m135.0k shares
CHARLES RIV LABS INTL INC CRL CRL 65,000 $17.6m65.0k shares
REGENERON PHARMACEUTICALS REGN REGN 17,000 $16.4m17.0k shares
PENUMBRA INC PEN PEN 70,000 $15.6m70.0k shares
DEXCOM INC DXCM DXCM 100,000 $13.9m100.0k shares
SHOCKWAVE MED INC SWAV SWAV 40,000 $13.0m40.0k shares
AVANTOR INC AVTR AVTR 500,000 $12.8m500.0k shares
CENCORA INC COR COR 50,000 $12.1m50.0k shares
COOPER COS INC COO COO 110,000 $11.2m110.0k shares
ALPINE IMMUNE SCIENCES INC NVLS NVLS 230,000 $9.1m230.0k shares
APELLIS PHARMACEUTICALS INC APLS APLS 150,000 $8.8m150.0k shares
EVOLENT HEALTH INC EVH EVH 250,000 $8.2m250.0k shares
TANDEM DIABETES CARE INC TNDM TNDM 225,000 $8.0m225.0k shares
4D MOLECULAR THERAPEUTICS IN FDMT FDMT 250,000 $8.0m250.0k shares
ALNYLAM PHARMACEUTICALS INC ALNY ALNY 50,000 $7.5m50.0k shares
MACROGENICS INC MGNX MGNX 500,000 $7.4m500.0k shares
INSPIRE MED SYS INC INSP INSP 33,000 $7.1m33.0k shares
ALKERMES PLC ALKS ALKS 250,000 $6.8m250.0k shares
BEIGENE LTD ONC ONC 40,000 $6.3m40.0k shares
REVVITY INC RVTY RVTY 50,000 $5.2m50.0k shares
ALIGN TECHNOLOGY INC ALGN ALGN 15,000 $4.9m15.0k shares
NATERA INC NTRA NTRA 50,000 $4.6m50.0k shares
LABORATORY CORP AMER HLDGS 20,000 $4.4m20.0k shares
AGILENT TECHNOLOGIES INC A A 30,000 $4.4m30.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
IONIS PHARMACEUTICALS INC IONS · Call IONSCall 500,000 $23.8m500.0k shares New
VIKING THERAPEUTICS INC VKTX · Call VKTXCall 250,000 $13.3m250.0k shares New
TARSUS PHARMACEUTICALS INC TARS · Put TARSPut 400,000 $10.9m400.0k shares New